Advertisement
Screener

DYADIC INTERNATIONAL INC (DYAI) Shareholder Equity

DYADIC INTERNATIONAL INC (DYAI) Shareholder Equity

  • 2026-06-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $48.69K; Additional Paid in CapitalUSD $114.02M; Treasury Stock, ValueUSD $18.93M.
  • 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $48.69K; Additional Paid in CapitalUSD $113.88M; Treasury Stock, ValueUSD $18.93M.
  • 2025-12-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $48.44K; Additional Paid in CapitalUSD $113.56M; Treasury Stock, ValueUSD $18.93M.
  • 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $48.44K; Additional Paid in CapitalUSD $113.37M; Treasury Stock, ValueUSD $18.93M.

DYADIC INTERNATIONAL INC Shareholder Equity

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endPreferred Stock, Value, Issued
USD
Common Stock, Value, Issued
USD
Additional Paid in Capital
USD
Treasury Stock, Value
USD
Retained Earnings (Accumulated Deficit)
USD
Stockholders' Equity Attributable to Parent
USD
Treasury Stock, Common, Shares
shares
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
USD
Treasury Stock, Value, Acquired, Cost Method
USD
Treasury Stock, Shares, Acquired
shares
Treasury Stock Acquired, Average Cost Per Share
USD/shares
2026-06-30(m)$48.69K$114.02M$18.93M$-97.53M$-2.39M12.25M3 month · $144.37K(m)(m)(m)
2026-03-31(m)$48.69K$113.88M$18.93M$-95.41M$-407.73K12.25M3 month · $139.30K(m)(m)(m)
2025-12-31(m)$48.44K$113.56M$18.93M$-93.45M$1.23M12.25M12 month · $930.18K(m)(m)(m)
2025-09-30(m)$48.44K$113.37M$18.93M$-91.88M$2.61M12.25M3 month · $172.35K(m)(m)(m)
2025-06-30(m)$42.39K$108.27M$18.93M$-89.91M$-529.70K12.25M3 month · $340.46K(m)(m)(m)
2025-03-31$0.00$42.37K$107.93M$18.93M$-88.11M$923.61K12.25M3 month · $225.03K(m)(m)(m)
2024-12-31$0.00$42.09K$107.44M$18.93M$-86.09M$2.47M12.25M12 month · $1.13M(m)(m)(m)
2024-09-30$0.00$41.84K$106.84M$18.93M$-84.54M$3.41M12.25M3 month · $247.39K(m)(m)(m)
2024-06-30$0.00$41.73K$106.39M$18.93M$-84.33M$3.17M12.25M3 month · $297.60K(m)(m)(m)
2024-03-31$0.00$41.44K$105.69M$18.93M$-82.29M$4.52M12.25M3 month · $306.48K(m)(m)(m)
2023-12-31$0.00$41.06K$105.04M$18.93M$-80.28M$5.88M12.25M12 month · $1.24M(m)(m)(m)
2023-09-30$0.00$41.06K$104.75M$18.93M$-78.21M$7.65M12.25M3 month · $281.31K(m)(m)(m)
2023-06-30$0.00$41.06K$104.47M$18.93M$-76.59M$8.99M12.25M3 month · $334.32K(m)(m)(m)
2023-03-31$0.00$41.06K$104.13M$18.93M$-74.44M$10.80M12.25M3 month · $330.64K(m)(m)(m)
2022-12-31$0.00$40.82K$103.46M$18.93M$-73.48M$11.09M12.25M12 month · $1.89M(m)(m)(m)
2022-09-30$0.00$40.72K$102.84M$18.93M$-71.34M$12.61M12.25M3 month · $499.92K(m)(m)(m)
2022-06-30$0.00$40.52K$101.98M$18.93M$-69.53M$13.56M12.25M3 month · $454.50K(m)(m)(m)
2022-03-31$0.00$40.52M$101.52B$18.93B$-66.24B$16.39M12.25M3 month · $453.79K(m)(m)(m)
2021-12-31$0.00$40.48K$101.03M$18.93M$-63.75M$18.39M12.25M12 month · $1.78M(m)(m)(m)
2021-09-30$0.00$40.33K$100.32M$18.93M$-59.53M$21.90M12.25M3 month · $457.21K(m)(m)(m)
2021-06-30$0.00$40.33K$99.87M$18.93M$-57.82M$23.16M12.25M3 month · $446.12K(m)(m)(m)
2021-03-31$0.00$39.81K$98.55M$18.93M$-53.97M$25.69M12.25M3 month · $421.07K(m)(m)(m)
2020-12-31$0.00$39.75K$98.01M$18.93M$-50.68M$28.45M12.25M12 month · $1.65M(m)(m)(m)
2020-09-30$0.00$39.74K$97.60M$18.93M$-48.72M$29.99M12.25M3 month · $400.68K
9 month · $1.26M
(m)(m)(m)
2020-06-30$0.00$39.74K$97.20M$18.93M$-46.22M$32.09M12.25M3 month · $436.61K
6 month · $863.55K
(m)(m)(m)
2020-03-31$0.00$39.71K$96.71M$18.93M$-43.57M$34.25M12.25M3 month · $426.94K(m)(m)(m)
2019-12-31$0.00$39.61K$96.11M$18.93M$-41.35M$35.86M12.25M12 month · $1.17M(m)(m)(m)
2019-09-30$0.00$39.47K$95.75M$18.93M$-39.61M$37.24M12.25M3 month · $144.18K
9 month · $1.03M
(m)(m)(m)
2019-06-30$0.00$39.37K$95.42M$18.93M$-37.91M$38.62M12.25M3 month · $580.60K
6 month · $890.17K
(m)(m)(m)
2019-03-31$0.00$38.97K$94.69M$18.93M$-35.22M$40.59M12.25M3 month · $309.56K(m)(m)(m)
2019-01-01(m)(m)(m)(m)(m)$42.45M(m)(m)(m)(m)(m)
2018-12-31$0.00$38.97K$94.39M$18.93M$-33.04M$42.45M12.25M12 month · $467.20K12 month · $2.30M
36 month · $21.81M
36 month · 14.39M36 month · 1.52
2018-09-30(m)(m)(m)(m)(m)$42.91M(m)3 month · $70.62K(m)(m)(m)
2018-08-31(m)(m)(m)(m)(m)(m)(m)(m)1 month · $1.93M
8 month · $2.30M
1 month · 1.38M
8 month · 1.64M
1 month · 1.40
8 month · 1.40
2018-06-30(m)(m)(m)(m)(m)$46.30M(m)3 month · $73.42K(m)(m)(m)
2018-03-31(m)(m)(m)(m)(m)$47.83M(m)3 month · $269.60K1 month · $143.82K1 month · 102.00K1 month · 1.41
2018-01-31(m)(m)(m)(m)(m)(m)(m)(m)1 month · $231.00K1 month · 165.00K1 month · 1.40
2018-01-01(m)(m)(m)(m)(m)$49.98M(m)(m)(m)(m)(m)
2017-12-31$0.00$38.94K$93.91M$16.63M$-27.35M$49.98M10.61M12 month · $643.43K4 month · $537.66K
12 month · $6.22M
4 month · 381.61K4 month · 1.41
2017-02-28(m)(m)(m)(m)(m)(m)(m)(m)1 month · $662.36K
2 month · $12.45M
1 month · 448.00K
2 month · 7.86M
1 month · 1.48
2 month · 1.58
2017-01-31(m)(m)(m)(m)(m)(m)(m)(m)1 month · $1.38M1 month · 867.51K1 month · 1.60
2017-01-11(m)(m)(m)(m)(m)(m)(m)(m)$3.64M2.36M1.54
2016-12-31(m)(m)(m)(m)(m)$57.69M(m)(m)12 month · $10.40M12 month · 6.55M12 month · 1.59
2016-01-12(m)(m)(m)(m)(m)(m)(m)(m)$2.88M2.14M1.35

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioCardia, Inc. (BCDA)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
IN8BIO, INC. (INAB)United States$0.012B-0.76
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23